Search for: "Juno Therapeutics, Inc v. Kite Pharma, Inc."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
26 Aug 2021, 7:34 pm
Both these examples of "from many, one" come to mind when considering the Federal Circuit's opinion today in Juno Therapeutics, Inc. v. [read post]
8 Nov 2022, 1:56 pm
Kite Pharma, Inc. [read post]
8 Nov 2022, 1:56 pm
Kite Pharma, Inc. [read post]
27 Aug 2021, 6:00 am
Juno Therapeutics v. [read post]
26 Aug 2021, 12:55 pm
Juno Therapeutics, Inc. v. [read post]
9 Jan 2022, 1:45 am
In a Court Appeal of the Federal Circuit (CAFC) decision last year, the same reasoning was applied to a broadly claimed molecule for CAR-T-cell therapy (Juno v Kite). [read post]
1 Jul 2022, 10:02 am
In Juno Therapeutics, Inc. v. [read post]
7 Oct 2021, 10:00 am
Recently, in Juno Therapeutics, Inc. v. [read post]
4 Oct 2022, 1:10 pm
Juno Therapeutics, Inc. v. [read post]
22 Dec 2022, 7:59 am
Kite Pharma, Inc., No. 21-1566. [read post]
26 Sep 2022, 4:49 am
Full Scope Written Description in Juno Therapeutics, Inc. v. [read post]
26 Oct 2022, 7:59 am
(relisted after the Sept. 28, Oct. 7 and Oct. 14 conferences) Juno Therapeutics, Inc. v. [read post]
13 Oct 2022, 6:28 am
(relisted after the Sept. 28 and Oct. 7 conferences) Juno Therapeutics, Inc. v. [read post]
2 Nov 2022, 11:43 am
New Relists Amgen Inc v. [read post]
